IP Library Granted Patent US 10,450,597
Granted Patent B2
US 10,450,597 · App. 14/605,363 · Granted Oct 22, 2019

Methods of preparing nucleic acids for sequencing

Inventors: Anthony John Iafrate (Newton, MA); Long Phi Le (Boston, MA); Zongli Zheng (Boston, MA); Jason Myers (Golden, CO); Joshua Stahl (Boulder, CO)
Assignees: THE GENERAL HOSPITAL CORPORATION; ARCHERDX, INC.
C12Q1/6806C12Q1/6809
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,450,597
App. No.
14/605,363
Granted
Oct 22, 2019
Kind
B2
Abstract

Aspects of the technology disclosed herein relate to methods for preparing and analyzing nucleic acids. In some embodiments, methods for preparing nucleic acids for sequence analysis (e.g., using next-generation sequencing) are provided herein.

Claims (33)

1. A method of preparing nucleic acids for analysis, the method comprising:

(a) contacting a first nucleic acid template comprising a sequence of a first strand of a double-stranded target nucleic acid with a complementary target-specific primer that comprises a target-specific hybridization sequence, under conditions to promote template-specific hybridization and extension of the target-specific primer;

(b) contacting a second nucleic acid template comprising a sequence of a second strand that is complementary to the sequence of the first strand of the double-stranded target nucleic acid with a plurality of different primers that share a common sequence that is 5′ to different hybridization sequences, under conditions to promote template-specific hybridization and extension of at least one of the plurality of different primers, wherein the different hybridization sequences have different 3′ ends, and wherein each primer of the plurality of different primers does not anneal to the same sequence of the double-stranded target nucleic acid as any other primer of the plurality of different primers,

wherein, following (a) and (b), an extension product is generated to contain both a sequence that is characteristic of the target-specific primer and a sequence that is characteristic of the at least one of the plurality of different primers; and

(c) subjecting the extension product to an amplification reaction comprising successive rounds of polymerase extension of i) a tail primer that comprises a 3′ sequence that specifically anneals to the complement of the common sequence and that comprises a 5′ tail sequence, and ii) a primer that specifically anneals to the complement of the target-specific hybridization sequence.

2. The method of claim 1 , wherein the first strand or the second strand of the double-stranded target nucleic acid is a ribonucleic acid.

3. The method of claim 1 , wherein the first strand or the second strand of the double-stranded target nucleic acid is a deoxyribonucleic acid.

4. The method of claim 1 , wherein steps (a) and (b) are performed sequentially.

5. The method of claim 1 , wherein the first nucleic acid template comprises an extension product resulting from the hybridization and extension of the at least one of the plurality of different primers in step (b).

6. The method of claim 1 , wherein the second nucleic acid template comprises an extension product resulting from the hybridization and extension of the target-specific primer in step (a).

7. The method of claim 2 , wherein the ribonucleic acid is a messenger RNA encoded from a chromosomal segment that comprises a genetic rearrangement.

8. The method of claim 3 , wherein the double-stranded target nucleic acid is a chromosomal segment that comprises a portion of a genetic rearrangement.

9. The method of claim 8 , wherein the genetic rearrangement is an inversion, deletion, or translocation.

10. The method of claim 1 , further comprising contacting the extension product or amplified extension product with an immobilized oligonucleotide under conditions in which hybridization occurs between the extension product and immobilized oligonucleotide.

11. The method of claim 1 , wherein the double-stranded target nucleic acid comprises a target portion having a known sequence and a flanking portion having an unknown sequence.

12. The method of claim 11 , wherein different hybridization sequences are complementary to the flanking portion.

13. The method of claim 11 , wherein the target-specific hybridization sequence is complementary to the target portion.

14. The method of claim 1 , wherein the target-specific primer further comprises, 5′ to the target-specific hybridization sequence, at least one of an index sequence, a barcode sequence and an adaptor sequence.

15. The method of claim 1 , wherein the common sequence comprises at least one of an index sequence, barcode sequence and an adaptor sequence.

16. The method of claim 14 , wherein the adaptor sequence is a cleavable adaptor sequence for immobilizing oligonucleotides in a flow cell.

17. The method of claim 1 , wherein the tail primer comprises a nucleic acid sequence identical to the common sequence.

18. The method of claim 1 , wherein the 5′ tail sequence comprises at least one of an index sequence, a barcode sequence, an adaptor sequence, and a sequencing primer hybridization sequence.

19. The method of claim 1 , wherein the primer that specifically anneals to the complement of the target-specific hybridization sequence comprises a sequence identical to the target-specific primer.

20. The method of claim 1 , wherein the primer that specifically anneals to the complement of the target-specific hybridization sequence comprises at least one modified internucleoside linkage.

21. The method of claim 1 , wherein the target-specific primer comprises at least one modified internucleoside linkage.

22. The method of claim 1 further comprising purifying the extension product prior to (c).

23. The method of claim 1 further comprising purifying the amplified product of (c).

24. The method of claim 1 , wherein the plurality of different primers can specifically anneal to sequences comprised by separate genes.

25. The method of claim 1 , wherein the plurality of different primers can specifically anneal to different portions of the first strand or the second strand of the double-stranded target nucleic acid comprised by a single gene.

26. The method of claim 1 , wherein the plurality of different primers can specifically anneal to different exons of a gene comprising the first strand or the second strand of the double-stranded target nucleic acid.

27. The method of claim 1 , wherein the first strand or the second strand of the double-stranded target nucleic acid is derived from a biological sample.

28. The method of claim 27 , wherein the first strand or the second strand of the double-stranded target nucleic acid is a cDNA produced from RNA in the biological sample.

29. The method of claim 1 , wherein the double-stranded target nucleic acid is derived from a sample comprising nucleic acids that have been ligated to an oligonucleotide comprising a barcode sequence.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2025
From: ARCHERDX, LLC
To: INVITAE CORPORATION
Reel/Frame 073239/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2024
From: INVITAE CORPORATION
To: LABORATORY CORPORATION OF AMERICA HOLDINGS
Reel/Frame 068822/0025 →
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ARCHERDX, LLC
Reel/Frame 065257/0335 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0442 →
SECURITY INTEREST Recorded Mar 7, 2023
From: ARCHERDX, LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 062908/0095 →
PATENT SECURITY AGREEMENT Recorded Oct 6, 2020
From: ARCHERDX, LLC
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 053992/0919 →
RELEASE OF SECURITY INTEREST Recorded Oct 2, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ARCHERDX, INC.
Reel/Frame 053960/0565 →
MERGER AND CHANGE OF NAME Recorded Oct 2, 2020
From: ARCHERDX, INC.; APOLLO MERGER SUB B LLC
To: ARCHERDX, LLC
Reel/Frame 053965/0492 →
PATENT SECURITY AGREEMENT Recorded May 10, 2019
From: ARCHERDX
To: PERCEPTIVE CREDIT HOLDINGS II, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 049149/0696 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2015
From: MYERS, JASON; STAHL, JOSHUA
To: ARCHERDX, INC.
Reel/Frame 035810/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2015
From: IAFRATE, ANTHONY JOHN; LE, LONG PHI; ZHENG, ZONGLI
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 035159/0657 →
Continuity (2)
Provisional Application 61931959 · Jan 27, 2014
Related Publication 20150211050A1 · Jul 30, 2015
Cited By (24)
US 12,203,142 US 12,221,653 US 12,234,509 US 12,260,934 US 12,270,073 US 12,305,229 US 12,305,235 US 12,385,096 US 12,410,476 US 12,460,264 US 12,486,542 US 12,492,429 US 12,509,728 US 12,553,083 US 12,553,086 US 12,571,034 US 12,571,043 US 12,571,047 US 12,630,864 US 12,644,149 US 12,649,946 US 12,655,483 US 12,662,704 US 12,716,090